'''RNA激活'''（RNA activation, RNAa) 是一种由小分子RNA介导的特异性基因表达上调机制，是李龙承等<ref name="pnas">{{cite journal |author=Li LC, Okino ST, Zhao H, ''et al.'' |title=Small dsRNAs induce transcriptional activation in human cells |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=103 |issue=46 |pages=17337–42 |pmid=17085592 |pmc=1859931 |doi=10.1073/pnas.0607015103 |url=http://www.pnas.org/cgi/pmidlookup?view=long&pmid=17085592|date=November 2006}}</ref>于2006年首先在人细胞中发现并命名的。随后，其他研究小组也报道了相似的现象，证明了RNA激活是从人及大小鼠等哺乳类动物到植物及线虫中的保守现象<ref name="ncb">{{cite journal |author=Janowski BA, Younger ST, Hardy DB, Ram R, Huffman KE, Corey DR |title=Activating gene expression in mammalian cells with promoter-targeted duplex RNAs |journal=Nat. Chem. Biol. |volume=3 |issue=3 |pages=166–73 |pmid=17259978 |doi=10.1038/nchembio860|date=March 2007}}</ref><ref name=LiLC>{{cite book|chapterurl=http://www.horizonpress.com/rnareg|author=Li LC|year=2008|chapter=Small RNA-Mediated Gene Activation|title=RNA and the Regulation of Gene Expression: A Hidden Layer of Complexity|publisher=Caister Academic Press|isbn=978-1-904455-25-7|access-date=2011-12-13|archive-date=2012-01-02|archive-url=https://web.archive.org/web/20120102091412/http://www.horizonpress.com/rnareg|dead-url=no}}</ref><ref>{{cite journal | author=Check E| title=RNA interference: hitting the on switch| journal=Nature| year=2007| volume=448| issue=7156| pages=855–8| pmid=17713502| doi=10.1038/448855a}}</ref><ref>{{cite journal| author=Huang V et al.| title=RNAa is conserved in mammalian cells| journal=PLoS One| year=2010| volume=5| pmid=20107511| issue=1| pmc=2809750| pages=e8848| doi=10.1371/journal.pone.0008848| url=http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0008848| access-date=2011-12-13| archive-date=2011-08-14| archive-url=https://web.archive.org/web/20110814143134/http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0008848| dead-url=no}}</ref><ref name="circRes">{{cite journal|author=Turunen MP, Lehtola T, Heinonen SE, Assefa GS, Korpisalo P, et al.|title=Efficient regulation of VEGF expression by promoter-targeted lentiviral shRNAs based on epigenetic mechanism: a novel example of epigenetherapy|journal=Circ Res.|year=2009|volume=105|issue=6|pages=604-609|url=http://circres.ahajournals.org/content/105/6/604.long|access-date=2011-12-13|archive-date=2014-10-21|archive-url=https://web.archive.org/web/20141021173002/http://circres.ahajournals.org/content/105/6/604.long|dead-url=no}}</ref><ref>{{Cite journal|title=Small activating RNA binds to the genomic target site in a seed-region-dependent manner|url=https://www.ncbi.nlm.nih.gov/pubmed/26873922|last=Meng|first=Xing|last2=Jiang|first2=Qian|date=2016-03-18|journal=Nucleic Acids Research|issue=5|doi=10.1093/nar/gkw076|volume=44|pages=2274–2282|issn=1362-4962|pmc=4797303|pmid=26873922|last3=Chang|first3=Nannan|last4=Wang|first4=Xiaoxia|last5=Liu|first5=Chujun|last6=Xiong|first6=Jingwei|last7=Cao|first7=Huiqing|last8=Liang|first8=Zicai|access-date=2018-08-20|archive-date=2018-08-20|archive-url=https://web.archive.org/web/20180820074904/https://www.ncbi.nlm.nih.gov/pubmed/26873922|dead-url=no}}</ref><ref>{{Cite journal|title=RNA-directed DNA methylation induces transcriptional activation in plants|url=https://www.ncbi.nlm.nih.gov/pubmed/19164525|last=Shibuya|first=Kenichi|last2=Fukushima|first2=Setsuko|date=2009-02-03|journal=Proceedings of the National Academy of Sciences of the United States of America|issue=5|doi=10.1073/pnas.0809294106|volume=106|pages=1660–1665|issn=1091-6490|pmc=2629447|pmid=19164525|last3=Takatsuji|first3=Hiroshi|access-date=2018-08-20|archive-date=2018-08-21|archive-url=https://web.archive.org/web/20180821131326/https://www.ncbi.nlm.nih.gov/pubmed/19164525|dead-url=no}}</ref><ref>{{Cite journal|title=The C. elegans CSR-1 argonaute pathway counteracts epigenetic silencing to promote germline gene expression|url=https://www.ncbi.nlm.nih.gov/pubmed/24360782|last=Seth|first=Meetu|last2=Shirayama|first2=Masaki|date=2013-12-23|journal=Developmental Cell|issue=6|doi=10.1016/j.devcel.2013.11.014|volume=27|pages=656–663|issn=1878-1551|pmc=3954781|pmid=24360782|last3=Gu|first3=Weifeng|last4=Ishidate|first4=Takao|last5=Conte|first5=Darryl|last6=Mello|first6=Craig C.|access-date=2018-08-20|archive-date=2018-08-21|archive-url=https://web.archive.org/web/20180821131339/https://www.ncbi.nlm.nih.gov/pubmed/24360782|dead-url=no}}</ref><ref>{{Cite journal|title=Autoregulation of lin-4 microRNA transcription by RNA activation (RNAa) in C. elegans|url=https://www.ncbi.nlm.nih.gov/pubmed/24398561|last=Turner|first=Michael J.|last2=Jiao|first2=Alan L.|date=2014|journal=Cell Cycle (Georgetown, Tex.)|issue=5|doi=10.4161/cc.27679|volume=13|pages=772–781|issn=1551-4005|pmc=3979913|pmid=24398561|last3=Slack|first3=Frank J.|access-date=2018-08-20|archive-date=2018-08-20|archive-url=https://web.archive.org/web/20180820105600/https://www.ncbi.nlm.nih.gov/pubmed/24398561|dead-url=no}}</ref>。RNA激活是由靶向基因启动子区域的双链小RNA（dsRNA）分子介导并需要Argonaute（AGO）蛋白的参与<ref name="pnas" /><ref>{{Cite journal|title=saRNA-guided Ago2 targets the RITA complex to promoters to stimulate transcription|url=https://www.ncbi.nlm.nih.gov/pubmed/26902284|last=Portnoy|first=Victoria|last2=Lin|first2=Szu Hua Sharon|date=2016-3|journal=Cell Research|issue=3|doi=10.1038/cr.2016.22|volume=26|pages=320–335|issn=1748-7838|pmc=4783471|pmid=26902284|last3=Li|first3=Kathy H.|last4=Burlingame|first4=Alma|last5=Hu|first5=Zheng-Hui|last6=Li|first6=Hao|last7=Li|first7=Long-Cheng|access-date=2018-08-20|archive-date=2018-08-21|archive-url=https://web.archive.org/web/20180821131319/https://www.ncbi.nlm.nih.gov/pubmed/26902284|dead-url=no}}</ref>。这类能够诱导RNA激活现象（即激活基因表达）的dsRNA被称为小激活RNA（small activating RNA，saRNA）<ref>{{Citation|title=Small Activating RNA Molecules and Methods of Use|date=2014-10-01|url=https://patents.google.com/patent/US20150104869A1/en|accessdate=2018-08-20|archive-date=2019-02-17|archive-url=https://web.archive.org/web/20190217165632/https://patents.google.com/patent/US20150104869A1/en|dead-url=no}}</ref>。saRNA可通过人工设计及化学合成而获得，也可为天然存在的内源性RNA如miRNA；前者介导的RNA激活被称为外源性RNA激活，后者为内源性RNA激活。

== 与RNA干扰（RNAi）的异同 ==
介导外源性RNA激活的saRNA与介导RNAi的[[siRNA|siRNA]]结构相似， 是含21个核苷酸的双链RNA（[[dsRNA|dsRNA]]），其兩条链在各自的3’端含2个核苷酸的突出。和[[RNAi|RNAi]]一样，RNAa也需要AGO蛋白特别是AGO2的参与，其作用可能是处理和活化saRNA分子，并介导saRNA与其启动子上的靶位点结合。与[[RNAi|RNAi]]（主要发生在胞浆）不同的是，RNA激活机制发生在细胞核，介导RNA激活的saRNA靶向启动子而不是mRNA序列，此外，RNA激活具有特殊的时效性，表现为其效果（基因表达上调）的出现呈现48小时左右的滞后，及效果的长久性（10-14天）<ref name="pnas" /><ref>{{Cite journal|title=Defining features and exploring chemical modifications to manipulate RNAa activity|url=https://www.ncbi.nlm.nih.gov/pubmed/20662764|last=Place|first=Robert F.|last2=Noonan|first2=Emily J.|date=2010-8|journal=Current Pharmaceutical Biotechnology|issue=5|volume=11|pages=518–526|issn=1873-4316|pmc=3413318|pmid=20662764|last3=Földes-Papp|first3=Zeno|last4=Li|first4=Long-Cheng|access-date=2018-08-20|archive-date=2018-08-21|archive-url=https://web.archive.org/web/20180821131352/https://www.ncbi.nlm.nih.gov/pubmed/20662764|dead-url=no}}</ref><ref>{{Cite journal|title=Novel RNA oligonucleotide improves liver function and inhibits liver carcinogenesis in vivo|url=https://www.ncbi.nlm.nih.gov/pubmed/23929703|last=Reebye|first=Vikash|last2=Sætrom|first2=Pål|date=2014-1|journal=Hepatology (Baltimore, Md.)|issue=1|doi=10.1002/hep.26669|volume=59|pages=216–227|issn=1527-3350|pmc=4655108|pmid=23929703|last3=Mintz|first3=Paul J.|last4=Huang|first4=Kai-Wen|last5=Swiderski|first5=Piotr|last6=Peng|first6=Ling|last7=Liu|first7=Cheng|last8=Liu|first8=Xiaoxuan|last9=Lindkaer-Jensen|first9=Steen|access-date=2018-08-20|archive-date=2018-08-20|archive-url=https://web.archive.org/web/20180820074827/https://www.ncbi.nlm.nih.gov/pubmed/23929703|dead-url=no}}</ref>。其机制被认为是因为RNA激活导致了表观遗传的改变<ref name="WIREsRNA">{{cite journal|author=Portnoy V, Huang V, Place RF, Li LC.|title=Small RNA and transcriptional upregulation|journal=Wiley Interdiscip Rev RNA|year=2011|volume=2|issue=5|pages=748-60|doi=10.1002/wrna.90|url=http://www.ncbi.nlm.nih.gov/pubmed/21823233|access-date=2011-12-13|archive-date=2015-05-26|archive-url=https://web.archive.org/web/20150526185029/http://www.ncbi.nlm.nih.gov/pubmed/21823233|dead-url=no}}</ref>。

== 内源性RNA激活 ==
2008年Place等<ref>{{cite journal|author=Place RF, Li LC, Pookot D, Noonan EJ, et al.|title=MicroRNA-373 induces expression of genes with complementary promoter sequences|journal=Proc Natl Acad Sci U S A.|year=2008|volume=105|issue=5|pages=1608-13|url=http://www.ncbi.nlm.nih.gov/pubmed/18227514|access-date=2011-12-13|archive-date=2012-06-01|archive-url=https://web.archive.org/web/20120601024517/http://www.ncbi.nlm.nih.gov/pubmed/18227514|dead-url=no}}</ref>报道了天然存在的miRNA也能够靶向启动子序列而诱导RNA激活。他们发现人CDH1及CSDC2基因启动子存在miR-373的靶位点，在人肿瘤细胞中引入miR-373的模拟物（mimics）能激活其靶基因的表达。后来，Huang等进一步证实了内源性miRNA介导的RNAa，并且发现该机制在正常及肿瘤细胞的增殖中起重要作用<ref>{{cite journal |author=Huang V, Place RF, Portnoy V, Wang J, Qi Z, Jia Z, Yu A, Shuman M, Yu J, Li LC |title=Upregulation of Cyclin B1 by miRNA and its implications in cancer |journal=Nucleic Acids Res |year=2011 Nov 3. [Epub ahead of print] |url=http://www.ncbi.nlm.nih.gov/pubmed/22053081 |access-date=2011-12-13 |archive-date=2014-06-07 |archive-url=https://web.archive.org/web/20140607075851/http://www.ncbi.nlm.nih.gov/pubmed/22053081 |dead-url=no }}</ref>。Xiao等还报道了靶向增强子区域的miRNA也能够诱导RNA激活<ref>{{Cite journal|title=miRNA-Mediated RNAa by Targeting Enhancers|url=https://www.ncbi.nlm.nih.gov/pubmed/28639195|last=Zou|first=Qingping|last2=Liang|first2=Ying|date=2017|journal=Advances in Experimental Medicine and Biology|doi=10.1007/978-981-10-4310-9_8|volume=983|pages=113–125|issn=0065-2598|pmid=28639195|last3=Luo|first3=Huaibing|last4=Yu|first4=Wenqiang|access-date=2018-08-20|archive-date=2018-08-20|archive-url=https://web.archive.org/web/20180820080226/https://www.ncbi.nlm.nih.gov/pubmed/28639195|dead-url=no}}</ref>。Chaluvally-Raghavan等发现miR-551b-3p通过靶向激活STAT3而促进卵巢癌细胞增殖、生存和肿瘤生长<ref>{{Cite journal|title=Direct Upregulation of STAT3 by MicroRNA-551b-3p Deregulates Growth and Metastasis of Ovarian Cancer|url=https://www.ncbi.nlm.nih.gov/pubmed/27160903|last=Chaluvally-Raghavan|first=Pradeep|last2=Jeong|first2=Kang Jin|date=2016-05-17|journal=Cell Reports|issue=7|doi=10.1016/j.celrep.2016.04.034|volume=15|pages=1493–1504|issn=2211-1247|pmc=4914391|pmid=27160903|last3=Pradeep|first3=Sunila|last4=Silva|first4=Andreia Machado|last5=Yu|first5=Shuangxing|last6=Liu|first6=Wenbin|last7=Moss|first7=Tyler|last8=Rodriguez-Aguayo|first8=Cristian|last9=Zhang|first9=Dong|access-date=2018-08-20|archive-date=2018-08-20|archive-url=https://web.archive.org/web/20180820080247/https://www.ncbi.nlm.nih.gov/pubmed/27160903|dead-url=no}}</ref>。目前对于有多少基因受到内源性RNA激活机制的调控还不清楚，但有研究发现miRNA<ref>{{Cite journal|title=MicroRNAs Form Triplexes with Double Stranded DNA at Sequence-Specific Binding Sites; a Eukaryotic Mechanism via which microRNAs Could Directly Alter Gene Expression|url=https://www.ncbi.nlm.nih.gov/pubmed/26844769|last=Paugh|first=Steven W.|last2=Coss|first2=David R.|date=2016-2|journal=PLoS computational biology|issue=2|doi=10.1371/journal.pcbi.1004744|volume=12|pages=e1004744|issn=1553-7358|pmc=4742280|pmid=26844769|last3=Bao|first3=Ju|last4=Laudermilk|first4=Lucas T.|last5=Grace|first5=Christy R.|last6=Ferreira|first6=Antonio M.|last7=Waddell|first7=M. Brett|last8=Ridout|first8=Granger|last9=Naeve|first9=Deanna|access-date=2018-08-20|archive-date=2018-08-20|archive-url=https://web.archive.org/web/20180820074706/https://www.ncbi.nlm.nih.gov/pubmed/26844769|dead-url=no}}</ref>及AGO蛋白<ref>{{Cite journal|title=Ago1 Interacts with RNA polymerase II and binds to the promoters of actively transcribed genes in human cancer cells|url=https://www.ncbi.nlm.nih.gov/pubmed/24086155|last=Huang|first=Vera|last2=Zheng|first2=Jiashun|date=2013|journal=PLoS genetics|issue=9|doi=10.1371/journal.pgen.1003821|volume=9|pages=e1003821|issn=1553-7404|pmc=3784563|pmid=24086155|last3=Qi|first3=Zhongxia|last4=Wang|first4=Ji|last5=Place|first5=Robert F.|last6=Yu|first6=Jingwei|last7=Li|first7=Hao|last8=Li|first8=Long-Cheng|access-date=2018-08-20|archive-date=2018-08-20|archive-url=https://web.archive.org/web/20180820080255/https://www.ncbi.nlm.nih.gov/pubmed/24086155|dead-url=no}}</ref>在人基因组的启动子区存在广泛的结合位点，提示miRNA可能在转录或者表观遗传水平调控大量的基因。

== RNA激活的应用 ==
RNA激活是一种简单易行的上调基因表达的方法，在生物医学领域具有广泛的潜在用途，包括作为工具用于研究基因的功能<ref>{{Cite journal|title=Prognostic value and function of KLF4 in prostate cancer: RNAa and vector-mediated overexpression identify KLF4 as an inhibitor of tumor cell growth and migration|url=https://www.ncbi.nlm.nih.gov/pubmed/21159640|last=Wang|first=Ji|last2=Place|first2=Robert F.|date=2010-12-15|journal=Cancer Research|issue=24|doi=10.1158/0008-5472.CAN-10-2414|volume=70|pages=10182–10191|issn=1538-7445|pmc=3076047|pmid=21159640|last3=Huang|first3=Vera|last4=Wang|first4=Xiaoling|last5=Noonan|first5=Emily J.|last6=Magyar|first6=Clara E.|last7=Huang|first7=Jiaoti|last8=Li|first8=Long-Cheng|access-date=2018-08-20|archive-date=2018-08-20|archive-url=https://web.archive.org/web/20180820074947/https://www.ncbi.nlm.nih.gov/pubmed/21159640|dead-url=no}}</ref>和对细胞进行重新编程<ref>{{Cite journal|title=Identification of small activating RNAs that enhance endogenous OCT4 expression in human mesenchymal stem cells|url=https://www.ncbi.nlm.nih.gov/pubmed/25232932|last=Wang|first=Ji|last2=Huang|first2=Vera|date=2015-02-01|journal=Stem Cells and Development|issue=3|doi=10.1089/scd.2014.0290|volume=24|pages=345–353|issn=1557-8534|pmc=4303016|pmid=25232932|last3=Ye|first3=Lin|last4=Bárcena|first4=Alicia|last5=Lin|first5=Guiting|last6=Lue|first6=Tom F.|last7=Li|first7=Long-Cheng|access-date=2018-08-20|archive-date=2018-08-20|archive-url=https://web.archive.org/web/20180820080301/https://www.ncbi.nlm.nih.gov/pubmed/25232932|dead-url=no}}</ref><ref>{{Cite journal|title=Induction of NANOG expression by targeting promoter sequence with small activating RNA antagonizes retinoic acid-induced differentiation|url=https://www.ncbi.nlm.nih.gov/pubmed/22339500|last=Wang|first=Xiaoling|last2=Wang|first2=Ji|date=2012-05-01|journal=The Biochemical Journal|issue=3|doi=10.1042/BJ20111491|volume=443|pages=821–828|issn=1470-8728|pmc=3327998|pmid=22339500|last3=Huang|first3=Vera|last4=Place|first4=Robert F.|last5=Li|first5=Long-Cheng|access-date=2018-08-20|archive-date=2018-08-20|archive-url=https://web.archive.org/web/20180820080308/https://www.ncbi.nlm.nih.gov/pubmed/22339500|dead-url=no}}</ref><ref>{{Cite journal|title=Manipulating Cx43 expression triggers gene reprogramming events in dermal fibroblasts from oculodentodigital dysplasia patients|url=https://www.ncbi.nlm.nih.gov/pubmed/26349540|last=Esseltine|first=Jessica L.|last2=Shao|first2=Qing|date=2015-11-15|journal=The Biochemical Journal|issue=1|doi=10.1042/BJ20150652|volume=472|pages=55–69|issn=1470-8728|pmid=26349540|last3=Huang|first3=Tao|last4=Kelly|first4=John J.|last5=Sampson|first5=Jacinda|last6=Laird|first6=Dale W.|access-date=2018-08-20|archive-date=2018-08-21|archive-url=https://web.archive.org/web/20180821125811/https://www.ncbi.nlm.nih.gov/pubmed/26349540|dead-url=no}}</ref><ref>{{Cite journal|title=A Short-activating RNA Oligonucleotide Targeting the Islet β-cell Transcriptional Factor MafA in CD34(+) Cells|url=https://www.ncbi.nlm.nih.gov/pubmed/23736775|last=Reebye|first=Vikash|last2=Sætrom|first2=Pål|date=2013-06-04|journal=Molecular Therapy. Nucleic Acids|doi=10.1038/mtna.2013.23|volume=2|pages=e97|issn=2162-2531|pmc=3696904|pmid=23736775|last3=Mintz|first3=Paul J.|last4=Rossi|first4=John J.|last5=Kasahara|first5=Noriyuki|last6=Nteliopoulos|first6=Georgios|last7=Nicholls|first7=Joanna|last8=Haoudi|first8=Abdelali|last9=Gordon|first9=Myrtle|access-date=2018-08-20|archive-date=2018-08-20|archive-url=https://web.archive.org/web/20180820074957/https://www.ncbi.nlm.nih.gov/pubmed/23736775|dead-url=no}}</ref>，以及作为治疗疾病的手段，包括肿瘤、心血管疾病、勃起功能障碍等<ref>{{Cite journal|title=Up-regulation of VEGF by small activator RNA in human corpus cavernosum smooth muscle cells|url=https://www.ncbi.nlm.nih.gov/pubmed/21819543|last=Chen|first=Ruibao|last2=Wang|first2=Tao|date=2011-10|journal=The Journal of Sexual Medicine|issue=10|doi=10.1111/j.1743-6109.2011.02412.x|volume=8|pages=2773–2780|issn=1743-6109|pmid=21819543|last3=Rao|first3=Ke|last4=Yang|first4=Jun|last5=Zhang|first5=Shilin|last6=Wang|first6=Shaogang|last7=Liu|first7=Jihong|last8=Ye|first8=Zhangqun|access-date=2018-08-20|archive-date=2018-08-20|archive-url=https://web.archive.org/web/20180820074720/https://www.ncbi.nlm.nih.gov/pubmed/21819543|dead-url=no}}</ref><ref name=":0">{{Cite news|url=https://clinicaltrials.gov/ct2/show/NCT02716012?term=cebpa&rank=1|title=First-in-Human Safety and Tolerability Study of MTL-CEBPA in Patients With Advanced Liver Cancer - Full Text View - ClinicalTrials.gov|accessdate=2018-08-20|language=en|archive-date=2018-08-20|archive-url=https://web.archive.org/web/20180820105618/https://clinicaltrials.gov/ct2/show/NCT02716012?term=cebpa&rank=1|dead-url=no}}</ref><ref>{{Cite journal|title=Intravesical delivery of small activating RNA formulated into lipid nanoparticles inhibits orthotopic bladder tumor growth|url=https://www.ncbi.nlm.nih.gov/pubmed/22869584|last=Kang|first=Moo Rim|last2=Yang|first2=Glen|date=2012-10-01|journal=Cancer Research|issue=19|doi=10.1158/0008-5472.CAN-12-1871|volume=72|pages=5069–5079|issn=1538-7445|pmid=22869584|last3=Place|first3=Robert F.|last4=Charisse|first4=Klaus|last5=Epstein-Barash|first5=Hila|last6=Manoharan|first6=Muthiah|last7=Li|first7=Long-Cheng|access-date=2018-08-20|archive-date=2018-08-21|archive-url=https://web.archive.org/web/20180821131359/https://www.ncbi.nlm.nih.gov/pubmed/22869584|dead-url=no}}</ref><ref>{{Cite journal|title=Development and Mechanism of Small Activating RNA Targeting CEBPA, a Novel Therapeutic in Clinical Trials for Liver Cancer|url=https://www.ncbi.nlm.nih.gov/pubmed/28882451|last=Voutila|first=Jon|last2=Reebye|first2=Vikash|date=2017-12-06|journal=Molecular Therapy: The Journal of the American Society of Gene Therapy|issue=12|doi=10.1016/j.ymthe.2017.07.018|volume=25|pages=2705–2714|issn=1525-0024|pmc=5768526|pmid=28882451|last3=Roberts|first3=Thomas C.|last4=Protopapa|first4=Pantelitsa|last5=Andrikakou|first5=Pinelopi|last6=Blakey|first6=David C.|last7=Habib|first7=Robert|last8=Huber|first8=Hans|last9=Saetrom|first9=Pal|access-date=2018-08-20|archive-date=2018-08-20|archive-url=https://web.archive.org/web/20180820075004/https://www.ncbi.nlm.nih.gov/pubmed/28882451|dead-url=no}}</ref><ref>{{Cite journal|title=Efficient regulation of VEGF expression by promoter-targeted lentiviral shRNAs based on epigenetic mechanism: a novel example of epigenetherapy|url=https://www.ncbi.nlm.nih.gov/pubmed/19696410|last=Turunen|first=Mikko P.|last2=Lehtola|first2=Tiia|date=2009-09-11|journal=Circulation Research|issue=6|doi=10.1161/CIRCRESAHA.109.200774|volume=105|pages=604–609|issn=1524-4571|pmid=19696410|last3=Heinonen|first3=Suvi E.|last4=Assefa|first4=Genet S.|last5=Korpisalo|first5=Petra|last6=Girnary|first6=Roseanne|last7=Glass|first7=Christopher K.|last8=Väisänen|first8=Sami|last9=Ylä-Herttuala|first9=Seppo|access-date=2018-08-20|archive-date=2018-08-20|archive-url=https://web.archive.org/web/20180820074818/https://www.ncbi.nlm.nih.gov/pubmed/19696410|dead-url=no}}</ref><ref>{{Cite journal|title=Epigenetic upregulation of endogenous VEGF-A reduces myocardial infarct size in mice|url=https://www.ncbi.nlm.nih.gov/pubmed/24587164|last=Turunen|first=Mikko P.|last2=Husso|first2=Tiia|date=2014|journal=PloS One|issue=2|doi=10.1371/journal.pone.0089979|volume=9|pages=e89979|issn=1932-6203|pmc=3935957|pmid=24587164|last3=Musthafa|first3=Haja|last4=Laidinen|first4=Svetlana|last5=Dragneva|first5=Galina|last6=Laham-Karam|first6=Nihay|last7=Honkanen|first7=Sanna|last8=Paakinaho|first8=Anne|last9=Laakkonen|first9=Johanna P.|access-date=2018-08-20|archive-date=2018-08-21|archive-url=https://web.archive.org/web/20180821131332/https://www.ncbi.nlm.nih.gov/pubmed/24587164|dead-url=no}}</ref>。目前，治疗肝癌的saRNA药已经进入临床试验<ref name=":0" />。

==參考來源==
{{reflist}}

==延伸阅读==
*{{cite journal |pages=855–8 |doi=10.1038/448855a |title=RNA interference: Hitting the on switch |year=2007 |last1=Check |first1=Erika |journal=Nature |volume=448 |issue=7156 |pmid=17713502}}
*{{cite book |author=Long-Cheng Li |title=RNA Activation |publisher=Springer Nature |location=Singapore |year=2017 |isbn=978-981-10-4310-9 |url=https://www.springer.com/us/book/9789811043093 |access-date=2018-08-20 |archive-date=2018-08-20 |archive-url=https://web.archive.org/web/20180820140832/https://www.springer.com/us/book/9789811043093 |dead-url=no }}
*{{cite journal |author=Garber K |title=Genetics. Small RNAs reveal an activating side |journal=Science |volume=314 |issue=5800 |pages=741–2 |pmid=17082428 |doi=10.1126/science.314.5800.741a |url=http://www.sciencemag.org/cgi/content/full/314/5800/741a |date=November 2006 |access-date=2011-12-13 |archive-date=2008-06-19 |archive-url=https://web.archive.org/web/20080619150437/http://sciencemag.org/cgi/content/full/314/5800/741a |dead-url=no }}
*How to get your genes switched on. [http://www.newscientist.com/channel/life/genetics/mg19225780.149-how-to-get-your-genes-switched-on.html New Scientist 16 November 2006]{{Wayback|url=http://www.newscientist.com/channel/life/genetics/mg19225780.149-how-to-get-your-genes-switched-on.html |date=20081020092329 }}

==外部連結==
*RNAa FAQs [http://www.urogene.org/RNAa-FAQs.html Li Lab, University of California San Francisco]{{Wayback|url=http://www.urogene.org/RNAa-FAQs.html |date=20111006045334 }}
*saRNAdb - Resource of small activating RNAs for up-regulating gene expression [http://bioinfo.imtech.res.in/manojk/sarna/ IMTech]{{Wayback|url=http://bioinfo.imtech.res.in/manojk/sarna/ |date=20180610115231 }}

[[Category:RNA|Category:RNA]]
[[Category:基因表現|Category:基因表現]]